Form D · Pharmaceuticals
RHYTHM PHARMACEUTICALS, INC.
Boston, MA · CIK 0001649904
Offering snapshot reported Jan 20, 2017 · SEC filing
- Reported sold
- $20.5M Offering amount: $40.9M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 20, 2017 | Initial | $20,475,001 | No comparison | 14 | SEC filing |
| Dec 10, 2015 | Amendment | $40,000,000 | $15,000,000vs Aug 12, 2015 | 12 | SEC filing |
| Aug 12, 2015 | Initial | $25,000,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-278910
Series A Preferred Stock
Source: Form D, filed Jan 20, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jean Christophe | Director |
| Neil Exter | Director |
| Todd Foley | Director |
| Keith Gottesdiener | Director, Executive, Promoter |
| Bart Henderson | Executive, Promoter |
| Christophe Jean | Director |
| Edward T. Mathers | Director |
| David J. Mc Girr | Director |
| David P. Meeker, M.D. | Director |
| Jonathan Silverstein | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
500 Boylston Street 11 Th Floor
Boston, MA, 02116
Boston, MA, 02116